Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Metro Healthcare BhdXKLS:0329 57 Forward PE Ratio is 37.50 as of Jul. 29, 2026. GuruFocus rates XKLS:0329 with a GF Score™ of 57/100 and a GF Value™ of RM0.31 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 314 Healthcare Providers & Services companies, Metro Healthcare Bhd ranks worse than 80.57% on this metric.
Metro Healthcare Bhd (XKLS:0329) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Metro Healthcare Bhd Forward PE Ratio Related Terms
Metro Healthcare Bhd Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for Metro Healthcare Bhd's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Metro Healthcare Bhd Forward PE Ratio Chart
Metro Healthcare Bhd Annual Data
Trend
2024-12
2025-12
Forward PE Ratio
0.20
38.33
Metro Healthcare Bhd Quarterly Data
2024-12
2025-03
2025-06
2025-09
2025-12
2026-03
Forward PE Ratio
0.20
0.19
32.50
39.17
38.33
36.67
XKLS:0329 vs HCA, THC, DVA: Forward PE Ratio Comparison
For the Medical Care Facilities subindustry, Metro Healthcare Bhd's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Metro Healthcare Bhd Forward PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Metro Healthcare Bhd's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Metro Healthcare Bhd's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Metro Healthcare Bhd (XKLS:0329) has a Forward PE Ratio of 37.50 as of Jul. 29, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Metro Healthcare Bhd and its competitors. According to the industry distribution chart, Metro Healthcare Bhd ranks #253 out of 314 companies in the Healthcare Providers & Services industry, placing it in the top 80.6%.
Is Metro Healthcare Bhd's Forward PE Ratio too high?
Metro Healthcare Bhd's current Forward PE Ratio is 37.50. The Healthcare Providers & Services industry median Forward PE Ratio is 18.33. Metro Healthcare Bhd's value of 37.50 is 104.6% above this industry median. Based on the distribution chart, Metro Healthcare Bhd ranks #253 out of 314 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Metro Healthcare Bhd has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Metro Healthcare Bhd's Forward PE Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Metro Healthcare Bhd ranks #253 out of 314 companies for Forward PE Ratio. This places Metro Healthcare Bhd in the lower half of its industry. The industry median Forward PE Ratio is 18.33. Metro Healthcare Bhd's value of 37.50 is 104.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Healthcare Providers & Services company?
The median Forward PE Ratio among Healthcare Providers & Services companies is 18.33, based on 314 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Metro Healthcare Bhd's current Forward PE Ratio of 37.50 is 104.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Metro Healthcare Bhd and its competitors. For the Healthcare Providers & Services industry, the median Forward PE Ratio is 18.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Metro Healthcare Bhd's current Forward PE Ratio is 37.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metro Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, Metro Healthcare Bhd (XKLS:0329) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.31, compared to a current price of RM0.22 — trading 29% below its estimated fair value. The current Forward PE Ratio is 37.50 and 104.6% above the Healthcare Providers & Services industry median of 18.33. Metro Healthcare Bhd's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Metro Healthcare Bhd (XKLS:0329), the current Forward PE Ratio is 37.50 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Metro Healthcare Bhd (XKLS:0329) Overvalued in 2026?
Based on GuruFocus' analysis, Metro Healthcare Bhd stock appears to be undervalued.
The current stock price of RM0.22 is trading 29% below its estimated GF Value™ of RM0.31.
GuruFocus considers Metro Healthcare Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0329:
Forward PE Ratio: 37.50
GF Value™: RM0.31 vs. price of RM0.22 (29% below fair value)
Industry Position: 104.6% above the Healthcare Providers & Services median (#253 of 314)
No single metric tells the full story. See the XKLS:0329 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Metro Healthcare Bhd is engaged in the provision of women healthcare services. The company offers various services such as obstetrics, gynecology impatient services, and diagnostic medical imaging services. It also provides semen analysis, intracytoplasmic sperm injection, blastocyst culture, assisted hatching, frozen embryo transfer, preimplantation genetic screening, and infertility consultation services. The company serves patients in Malaysia. The firm's business segment includes O&G healthcare services, Complementary services, and Hospital services.
57GF Score
Get the complete analysis for XKLS:0329
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0329 has been successfully added to your 
